The cardioprotective role of beta-blockers in patients with diabetes mellitus

Research output: Contribution to journalArticle

Authors

Abstract

This paper reviews the role of beta-blockers in the prevention of cardiovascular morbidity and mortality in patients with diabetes mellitus. There is good evidence from randomized controlled trials that beta-blockers, in particular the lipophilic agents, substantially reduce cardiovascular mortality and morbidity. However, hitherto beta-blockers have been underused in diabetic patients, perhaps because of perceived risks of beta-blocker therapy. Reappraisal of the evidence suggests that the traditional reluctance to use beta-blockers in this group is based on fears of adverse effects that are largely unfounded.

Details

Original languageEnglish
Pages (from-to)233-242
Number of pages10
JournalJournal of Clinical Pharmacy and Therapeutics
Volume27
Issue number4
Publication statusPublished - 1 Aug 2002

Keywords

  • diabetes mellitus, coronary heart disease, cardioprotection, sudden death, beta-blocker